S&P 500   3,315.57 (+1.05%)
DOW   27,288.18 (+0.52%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
S&P 500   3,315.57 (+1.05%)
DOW   27,288.18 (+0.52%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
S&P 500   3,315.57 (+1.05%)
DOW   27,288.18 (+0.52%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
S&P 500   3,315.57 (+1.05%)
DOW   27,288.18 (+0.52%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
Log in
NASDAQ:AEMD

Aethlon Medical Stock Forecast, Price & News

$1.29
-0.05 (-3.73 %)
(As of 09/22/2020 03:59 PM ET)
Add
Compare
Today's Range
$1.29
Now: $1.29
$1.37
50-Day Range
$1.29
MA: $1.57
$2.12
52-Week Range
$0.76
Now: $1.29
$6.89
Volume7,399 shs
Average Volume1.77 million shs
Market Capitalization$15.57 million
P/E RatioN/A
Dividend YieldN/A
Beta0.33
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosomal biomarkers to diagnose and monitor life-threatening disease conditions, such as cancer and neurological disorders; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. The company was founded in 1991 and is based in San Diego, California.
Read More
Aethlon Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.67 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AEMD
CUSIPN/A
Phone858-459-7800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$650,000.00
Book Value$0.99 per share

Profitability

Net Income$-6,390,000.00

Miscellaneous

Employees6
Market Cap$15.57 million
Next Earnings Date11/6/2020 (Estimated)
OptionableNot Optionable
$1.29
-0.05 (-3.73 %)
(As of 09/22/2020 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AEMD News and Ratings via Email

Sign-up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Aethlon Medical (NASDAQ:AEMD) Frequently Asked Questions

How has Aethlon Medical's stock price been impacted by Coronavirus (COVID-19)?

Aethlon Medical's stock was trading at $1.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, AEMD shares have decreased by 35.2% and is now trading at $1.29.
View which stocks have been most impacted by COVID-19
.

When is Aethlon Medical's next earnings date?

Aethlon Medical is scheduled to release its next quarterly earnings announcement on Friday, November 6th 2020.
View our earnings forecast for Aethlon Medical
.

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) posted its quarterly earnings data on Tuesday, August, 11th. The medical equipment provider reported ($0.15) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.10) by $0.05.
View Aethlon Medical's earnings history
.

Are investors shorting Aethlon Medical?

Aethlon Medical saw a decrease in short interest in August. As of August 31st, there was short interest totaling 472,000 shares, a decrease of 29.8% from the August 15th total of 671,900 shares. Based on an average daily trading volume, of 2,460,000 shares, the days-to-cover ratio is presently 0.2 days. Approximately 4.0% of the company's shares are short sold.
View Aethlon Medical's Short Interest
.

Who are some of Aethlon Medical's key competitors?

What other stocks do shareholders of Aethlon Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia Oyj (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), Crispr Therapeutics (CRSP), Novavax (NVAX), OrganiGram (OGI), AT&T (T) and Aurora Cannabis (ACB).

Who are Aethlon Medical's key executives?

Aethlon Medical's management team includes the following people:
  • Mr. James B. Frakes, CFO, Sr. VP of Fin. & Sec. (Age 62)
  • Mr. James A. Joyce, Consultant (Age 57)
  • Dr. Timothy C. Rodell, Interim CEO & Director (Age 68)
  • Mr. Sunil Sawhney, Head of Clinical Studies
  • Dr. Richard H. Tullis, Consultant (Age 74)

What is Aethlon Medical's stock symbol?

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

Who are Aethlon Medical's major shareholders?

Aethlon Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Jane Street Group LLC (0.14%) and Two Sigma Securities LLC (0.11%).

Which major investors are buying Aethlon Medical stock?

AEMD stock was acquired by a variety of institutional investors in the last quarter, including Jane Street Group LLC, and Two Sigma Securities LLC.

How do I buy shares of Aethlon Medical?

Shares of AEMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aethlon Medical's stock price today?

One share of AEMD stock can currently be purchased for approximately $1.29.

How big of a company is Aethlon Medical?

Aethlon Medical has a market capitalization of $15.57 million and generates $650,000.00 in revenue each year. The medical equipment provider earns $-6,390,000.00 in net income (profit) each year or ($1.87) on an earnings per share basis. Aethlon Medical employs 6 workers across the globe.

What is Aethlon Medical's official website?

The official website for Aethlon Medical is www.aethlonmedical.com.

How can I contact Aethlon Medical?

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The medical equipment provider can be reached via phone at 858-459-7800 or via email at [email protected]

This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.